Your browser doesn't support javascript.
loading
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.
Patchett, Amanda L; Latham, Roger; Brettingham-Moore, Kate H; Tovar, Cesar; Lyons, A Bruce; Woods, Gregory M.
Afiliação
  • Patchett AL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Latham R; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
  • Brettingham-Moore KH; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
  • Tovar C; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Lyons AB; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
  • Woods GM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; School of Medicine, University of Tasmania, Hobart, TAS, Australia. Electronic address: G.M.Woods@utas.edu.au.
Dev Comp Immunol ; 53(1): 123-33, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26182986
Devil facial tumour disease (DFTD) is a fatally transmissible cancer that threatens the Tasmanian devil population. As Tasmanian devils do not produce an immune response against DFTD cells, an effective vaccine will require a strong adjuvant. Activation of innate immune system cells through toll-like receptors (TLRs) could provide this stimulation. It is unknown whether marsupials, including Tasmanian devils, express functional TLRs. We isolated RNA from peripheral blood mononuclear cells and, with PCR, detected transcripts for TLRs 2, 3, 4, 5, 6, 7, 8, 9, 10 and 13. Stimulation of the mononuclear cells with agonists to these TLRs increased the expression of downstream TLR signaling products (IL1α, IL6, IL12A and IFNß). Our data provide the first evidence that TLR signaling is functional in the mononuclear cells of the Tasmanian devil. Future DFTD vaccination trials will incorporate TLR agonists to enhance the immune response against DFTD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Faciais / Leucócitos Mononucleares / Receptores Toll-Like / Imunidade Inata / Marsupiais Limite: Animals Idioma: En Revista: Dev Comp Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Faciais / Leucócitos Mononucleares / Receptores Toll-Like / Imunidade Inata / Marsupiais Limite: Animals Idioma: En Revista: Dev Comp Immunol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos